Search Result "Electronegative LDL"
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
Misfolding of Apoprotein B-100, LDL Aggregation and 17-β -estradiol in Atherogenesis
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 20 Year: 2014 Page: 2276-2283
Author(s): R. Brunelli,M. De Spirito,G. Mei,M. Papi,G. Perrone,C. Stefanutti,T. Parasassi
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Multiple-modified Low-Density Lipoprotein as Atherogenic Factor of Patients' Blood: Development of Therapeutic Approaches to Reduce Blood Atherogenicity
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 932-936
Author(s): Nikita G. Nikifirov,Emile R. Zakiev,Natalia V. Elizova,Vasily N. Sukhorukov,Alexander N. Orekhov
Recent Advances on Detection of Modified Forms of Low-Density Lipoproteins
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 3 Issue: 1 Year: 2009 Page: 28-34
Author(s): Tanize E.S. Faulin, Maria C.C. Garcia, Dulcineia S.P. Abdalla
Effect of Electronegative Groups on the Antimicrobial Activity of 3, 5- Disubstituted Thiazolidine-2,4-diones
Journal: Anti-Infective Agents
Volume: 12 Issue: 1 Year: 2014 Page: 112-119
Author(s): Radhe S. Bahare,Swastika Ganguly
Pathophysiological Role and Clinical Significance of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Bound to LDL and HDL
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6256-6269
Author(s): Constantinos C. Tellis, Alexandros D. Tselepis
The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1576-1593
Author(s): Hiroyuki Itabe,Rina Kato,Naoko Sawada,Takashi Obama,Matsuo Yamamoto
Modified and Dysfunctional Lipoproteins in Atherosclerosis: Effectors or Biomarkers?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1512-1524
Author(s): Alexander N. Orekhov,Igor A. Sobenin
Prospects for the Use of Sialidase Inhibitors in Anti-atherosclerotic Therapy
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 12 Year: 2021 Page: 2438-2450
Author(s): Igor A. Sobenin,Alexander M. Markin,Victor Y. Glanz,Yuliya V. Markina,Wei-Kai Wu,Veronika A. Myasoedova,Alexander N. Orekhov